We’ve recently updated our valuation analysis.

Iteris Valuation

Is ITI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ITI?

Other financial metrics that can be useful for relative valuation.

ITI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1x
Enterprise Value/EBITDA-10.9x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ITI's PS Ratio compare to its peers?

The above table shows the PS ratio for ITI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average13.9x
HOLO MicroCloud Hologram
1.8xn/aUS$128.7m
TROO TROOPS
49.5xn/aUS$182.4m
PWFL PowerFleet
0.8x11.0%US$107.4m
PRST Presto Automation
3.5xn/aUS$107.9m
ITI Iteris
0.9x11.7%US$130.4m

Price-To-Sales vs Peers: ITI is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (13.9x).


Price to Earnings Ratio vs Industry

How does ITI's PE Ratio compare vs other companies in the US Electronic Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a11.6%
n/an/an/a

Price-To-Sales vs Industry: ITI is good value based on its Price-To-Sales Ratio (0.9x) compared to the US Electronic industry average (1.6x)


Price to Sales Ratio vs Fair Ratio

What is ITI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ITI PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ratio0.7x

Price-To-Sales vs Fair Ratio: ITI is expensive based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).


Share Price vs Fair Value

What is the Fair Price of ITI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ITI ($3.08) is trading below our estimate of fair value ($9.37)

Significantly Below Fair Value: ITI is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ITI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$3.08
US$4.50
+46.1%
28.3%US$6.00US$3.00n/a4
Nov ’23US$2.99
US$5.67
+89.5%
54.6%US$10.00US$3.00n/a3
Oct ’23US$2.97
US$5.67
+90.8%
54.6%US$10.00US$3.00n/a3
Sep ’23US$3.12
US$5.67
+81.6%
54.6%US$10.00US$3.00n/a3
Aug ’23US$2.70
US$6.00
+122.2%
49.1%US$10.00US$3.00n/a3
Jul ’23US$2.83
US$6.00
+112.0%
49.1%US$10.00US$3.00n/a3
Jun ’23US$2.70
US$7.88
+191.7%
34.3%US$11.00US$4.50n/a4
May ’23US$2.58
US$7.88
+205.2%
34.3%US$11.00US$4.50n/a4
Apr ’23US$3.04
US$7.88
+159.0%
34.3%US$11.00US$4.50n/a4
Mar ’23US$3.19
US$7.88
+146.9%
34.3%US$11.00US$4.50n/a4
Feb ’23US$3.93
US$8.75
+122.6%
21.9%US$11.00US$6.00n/a4
Jan ’23US$4.00
US$8.75
+118.8%
21.9%US$11.00US$6.00n/a4
Dec ’22US$4.51
US$8.33
+84.8%
15.0%US$10.00US$7.00n/a3
Nov ’22US$5.47
US$9.00
+64.5%
9.1%US$10.00US$8.00US$2.993
Oct ’22US$5.19
US$9.00
+73.4%
9.1%US$10.00US$8.00US$2.973
Sep ’22US$5.67
US$9.00
+58.7%
9.1%US$10.00US$8.00US$3.123
Aug ’22US$6.23
US$9.00
+44.5%
9.1%US$10.00US$8.00US$2.703
Jul ’22US$6.55
US$9.50
+45.0%
11.8%US$11.00US$8.00US$2.834
Jun ’22US$7.20
US$9.25
+28.5%
11.8%US$11.00US$8.00US$2.704
May ’22US$6.75
US$9.25
+37.0%
11.8%US$11.00US$8.00US$2.584
Apr ’22US$6.44
US$9.20
+42.9%
16.0%US$12.00US$8.00US$3.045
Mar ’22US$6.79
US$9.20
+35.6%
16.0%US$12.00US$8.00US$3.195
Feb ’22US$6.96
US$8.80
+26.4%
22.0%US$12.00US$6.00US$3.935
Jan ’22US$5.65
US$8.80
+55.8%
22.0%US$12.00US$6.00US$4.005
Dec ’21US$4.99
US$8.20
+64.3%
16.6%US$10.00US$6.00US$4.515
Nov ’21US$3.77
US$8.00
+112.2%
14.3%US$9.00US$6.00US$5.475

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies